Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy

por Fareed, K R, Al-Attar, A, Soomro, I N, Kaye, P V, Patel, J, Lobo, D N, Parsons, S L, Madhusudan, S
Publicado 2010

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers

por Al-Attar, A, Gossage, L, Fareed, K R, Shehata, M, Mohammed, M, Zaitoun, A M, Soomro, I, Lobo, D N, Abbotts, R, Chan, S, Madhusudan, S
Publicado 2010